Anti-CD2 monoclonal antibody 12-15
Latest Information Update: 26 Aug 2002
Price :
$50 *
At a glance
- Originator Medical University of South Carolina
- Class Monoclonal antibodies
- Mechanism of Action CD2 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart transplant rejection
Most Recent Events
- 14 Jul 1998 No-Development-Reported for Heart transplant rejection in USA (Unknown route)
- 15 Dec 1995 New profile
- 14 Dec 1995 Preclinical development for Heart transplant rejection in USA (Unknown route)